 Recent improvements, such as optimal dosing, allergen modification to reduce allergenicity while maintaining immunogenicity, adjuvant adsorption to control release and adjuvant activity to assist immunomodulatory action are being explored to reduce the risk of anaphylaxis and decrease the commitment to multiple injections. 